Design of accurate COPD classification model based on volatile organic compounds from exhaled air

J. van Berkel, J. Dallinga, G. Möller, R. Godschalk, E. Wouters, F. J. van Schooten (Maastricht, Netherlands)

Source: Annual Congress 2008 - New challenges and maintained quality: lung function for the future
Session: New challenges and maintained quality: lung function for the future
Session type: Oral Presentation
Number: 342
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. van Berkel, J. Dallinga, G. Möller, R. Godschalk, E. Wouters, F. J. van Schooten (Maastricht, Netherlands). Design of accurate COPD classification model based on volatile organic compounds from exhaled air. Eur Respir J 2008; 32: Suppl. 52, 342

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009


Value of exhaled volatile organic compounds in monitoring airway disease
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Standardization of exhaled volatile organic compounds (VOCs) measurement
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function
Source: International Congress 2015 – The next generation of lung function tests
Year: 2015



Volatile organic compounds (VOC) in exhaled breath of patients with COPD
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Limited clinical value of exhaled volatile organic compound measurements in childhood asthma
Source: ERJ Open Res, 4 (4) 00026-2018; 10.1183/23120541.00026-2018
Year: 2018



Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 208s
Year: 2003

Exhaled volatile organic compounds as markers for medication use in asthma
Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019
Year: 2020



Determination of exhaled ethane, pentane and isoprene from humans: method development and validation
Source: Eur Respir J 2001; 18: Suppl. 33, 269s
Year: 2001

Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Volatile organic compounds (VOC) in exhaled air sampled through the working channel of a bronchoscope in lung cancer patients
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

Comprehensive analysis of volatile organic compounds in human breath gas samples
Source: Eur Respir J 2003; 22: Suppl. 45, 131s
Year: 2003

Exhaled volatile organic compounds for better asthma control: could it be a future noninvasive adherence test?
Source: Eur Respir J, 55 (2) 1902112; 10.1183/13993003.02112-2019
Year: 2020



Diet and alcohol affect exhaled volatile organic compounds (VOCs)
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Interpretation of exhaled volatile organic compounds
Source: Eur Respir Monogr 2010; 49: 115-129
Year: 2010